Research Paper Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma Full text PDF
Research Paper Epidemiological Trends and Shared Molecular Signatures of Pancreatic Ductal Adenocarcinoma and Diabetes: An Integrative Analysis Based on Global Burden of Disease and Gene Expression Omnibus Datasets Full text PDF
Research Paper CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons Full text PDF
Review miR-150-5p at the Interface of Cancer Biology and Immune Regulation: Dual Roles, Mechanisms, and Therapeutic Opportunities Full text PDF
Research Paper Vemurafenib Induces Apoptosis via JNK Activation and AKT Inhibition in Hepatocellular Carcinoma Full text PDF PubMed PMC
Research Paper Serum Thyroid Biomarkers for Diagnosing Malignant Thyroid Nodules: A Machine Learning Approach with External and Causal Validation Full text PDF PubMed PMC
Issue 5; 2026
Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...
Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma
Background: Lung adenocarcinoma (LUAD) exhibits extensive molecular heterogeneity and poor prognosis, necessitating novel epigenetic biomarkers. N6-methyladenosine (m6A) modification, a a pivotal epigenetic regulator of RNA, is frequently dysregulated in LUAD, yet its systematic roles in clinical prognosis and the tumor microenvironment (TME) remain poorly elucidated. Methods: Transcriptomic profiles and clinical data from large-scale cohorts were ...
Background: Thyroid nodules (TNs) are common, and accurate malignancy risk stratification is critical for clinical decision-making. Although serum thyroid biomarkers are routinely measured, their contribution to malignancy discrimination remains insufficiently characterized. Thus, we aimed to develop a practical and biologically grounded model for identifying malignant TNs using routinely clinical data. Methods: We retrospectively analyzed 5537 patients ...